April 2023 – Kinstellar is delighted to announce that it has advised a holding company of a leading Ukrainian pharmaceutical company, YURiA PHARM, on the two-stage acquisition of a pharmaceutical company in Uzbekistan.
The acquisition, which was supported by financing from an international financial institution, will enable Yuria Pharm to maintain exports despite the war, localise and increase production in Uzbekistan as well as allocate more critical medicine to the market in Ukraine.
Our team undertook comprehensive due diligence and advised on transactional, corporate governance, regulatory, anti-trust as well as financing-related and other matters. Kinstellar’s team was led by Sherzod Yunusov, Partner, with the support of Kamilla Ubaydullaeva, Malika Azimova, and Jamshid Yusupov (Associates), Sabina Sharipova and Shohruh Ergashev (Junior Associates) and Feruza Kamolova (Legal Assistant). Anthony O’Connor, Partner in our Budapest office, advised on English law matters, assisted by Csenge Koller (Senior Associate) and Anna Szilágyi (Junior Associate).